1 terminated. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Terminated 1 |
Follow Hematologic Malignancy: new trials by email Literature Review of Hematologic Malignancy trials Research Report on Hematologic Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation Ceftolozane / Tazobactam Injection - Pneumonia, Hematologic Malignancy | Phase 4 | Terminated | Weill Medical College of Cornell University | 17 | 2023-01-10 | 2026-01-21 |
Bacteremia (1) · Gram-Negative Bacterial Infections (1) · Hematologic Neoplasms (1) · Pneumonia (1) · Pseudomonas Infections (1)
Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Infections (1) · Inflammation (1) · Lung Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Sepsis (1) · Systemic Inflammatory Response Syndrome (1)
ceftolozane, tazobactam drug combination (1)
Weill Medical College of Cornell University (1)
United States (1)
Markus Plate, MD (1)